What Analysts Said After Bristol-Myers' Quick Lung Drug Approval
March 05, 2015 at 09:35 AM EST
Bristol-Myers Squibb Co (NYSE: BMY) shot higher on Wednesday, gaining more than 6 percent after its lung cancer drug received ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.